ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 71 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $54,000 | -3.6% | 10,045 | +0.4% | 0.03% | -46.4% |
Q3 2016 | $56,000 | -62.4% | 10,000 | -50.1% | 0.06% | -72.5% |
Q1 2016 | $149,000 | +79.5% | 20,045 | +99.6% | 0.20% | +300.0% |
Q4 2015 | $83,000 | -75.7% | 10,045 | -64.6% | 0.05% | -75.9% |
Q2 2015 | $341,000 | -62.8% | 28,408 | -66.6% | 0.21% | -65.4% |
Q1 2015 | $917,000 | +201.6% | 85,090 | +41.8% | 0.61% | +273.2% |
Q4 2014 | $304,000 | +1069.2% | 60,000 | +500.0% | 0.16% | +811.1% |
Q3 2014 | $26,000 | -35.0% | 10,000 | 0.0% | 0.02% | -28.0% |
Q2 2014 | $40,000 | -65.2% | 10,000 | -60.0% | 0.02% | -59.7% |
Q1 2014 | $115,000 | +5.5% | 25,000 | 0.0% | 0.06% | +17.0% |
Q4 2013 | $109,000 | -44.9% | 25,000 | -50.0% | 0.05% | -55.8% |
Q3 2013 | $198,000 | +465.7% | 50,000 | +199.4% | 0.12% | +380.0% |
Q2 2013 | $35,000 | – | 16,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
tru Independence LLC | 213,712 | $701,000 | 0.10% |
AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |